Capstan CEO Maggie Nixon discusses first-in-human feedback, the all-at-once approach, regulatory strategy and the tricuspid ...

Protecting your heart starts with understanding how it works. Heart valve diseases are conditions that can disrupt the flow ...

Jones Financial Companies Lllp lifted its position in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 19.9% during the ...

In this randomized controlled trial, a transcatheter tricuspid-valve replacement provided a mortality benefit compared to ...

A family say they have been "left in the dark" over a heart transplant for their daughter - three months after planned ...

Zacks Research boosted their Q1 2025 earnings estimates for shares of Edwards Lifesciences in a research report issued to ...

According to the medical provider, the CentraCare Heart and Vascular team accomplished another milestone when they used two ...

After 12 days of observation with no improvement, the patient underwent cardiac surgery for occluder removal, VSD repair, and tricuspid valve repair. Intraoperatively, damage was identified at the ...

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Capstan Medical, a developer of robotic-enabled minimally invasive solutions to address heart valve disease, announced today ...